AbbVie Inc. (ABBV)

Exchange: New York Stock Exchange
Currency: USD

Price: 109.14 (Close)



52 Week range 200d Moving Avg. Beta
75.49 – 120.07 111.23 0.00
Dividend Dividend Yield Ex-Dividend date
5.11 4.68% 2021-10-14
P/E Ratio Latest EPS DGR 3 years
29.42 3.68 22.62%
Dividend Growth


AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.


Sector: Industry:
Health Technology Pharmaceuticals: Major
Dividend Aristocrat

Environment, Social and Governance (ESG) Ratings

Total ESG Score

35 – 66 percentile


5 – 7 percentile


23 – 7 percentile


16 – 7 percentile

Controversy level



see MSCI ESG rating explained


Dividend aristocrats in the same sector are:
– Cardinal Health Inc. (CAH)
– Abbott Laboratories (ABT)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)

Dividend Safety Metrics

Latest EPS 3.68
Annual Payout 5.11
Payout Ratio 138.86%
Dividend growth 25 Years
Dividend Score 85
Dividend Coverage Ratio 0.73
Altman-Z score 2.01 Grey Zone


Estimated Future Total Return Metrics

Total return last 5Y 16.00%
Dividend growth 5Y 18.50%
Current dividend yield 4.68%
Average dividend yield last 5Y 3.88%
Estimated EPS growth next 5Y 4.50%
Extra return due to over/under valuation 3.80%
Estimated future return 5Y (CAGR) 12.20%


AbbVie Inc. (ABBV) Valuation

AbbVie Inc.’s current dividend yield of 4.68% is 21% above its 5-year average. The 5-year average dividend yield is 3.88% (see red-line in chart). This indicates the stock may be undervalued today.

AbbVie Inc. (ABBV) Performance

The chart below displays the total price return(%) of AbbVie Inc. for different periods:


AbbVie Inc. (ABBV) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of AbbVie Inc. for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
4.68 5.11 138.86% 25 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 22.62%
5 Year Growth Rate (CAGR) 18.50%
10 Year Growth Rate (CAGR) 0.00%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 5.200 -%
2020 4.720 10.3%
2019 4.280 19.2%
2018 3.590 40.2%
2017 2.560 12.3%
2016 2.280 12.9%
2015 2.020 21.7%
2014 1.660 3.8%
2013 1.600 0.0%

AbbVie Inc. (ABBV) Dividend Payment History